Luri-Rey C, Teijeira A, Wculek S, de Andrea C, Herrero C, Lopez-Janeiro A
Nat Rev Cancer. 2025; .
PMID: 39881005
DOI: 10.1038/s41568-024-00785-5.
DeGolier K, Danis E, DAntonio M, Cimons J, Yarnell M, Kedl R
Nat Immunol. 2025; 26(1):68-81.
PMID: 39747430
PMC: 11695263.
DOI: 10.1038/s41590-024-02034-1.
Xie L, Fang J, Yu J, Zhang W, He Z, Ye L
MedComm (2020). 2023; 4(5):e390.
PMID: 37829505
PMC: 10565399.
DOI: 10.1002/mco2.390.
Bowakim-Anta N, Acolty V, Azouz A, Yagita H, Leo O, Goriely S
Front Immunol. 2023; 14:1023064.
PMID: 36993956
PMC: 10041113.
DOI: 10.3389/fimmu.2023.1023064.
Daniels M, Luera D, Teixeiro E
Front Immunol. 2023; 14:1129191.
PMID: 36911729
PMC: 9998984.
DOI: 10.3389/fimmu.2023.1129191.
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8 T cells.
de Mey W, Locy H, De Ridder K, De Schrijver P, Autaers D, Lakdimi A
Front Immunol. 2023; 14:1111523.
PMID: 36860873
PMC: 9969480.
DOI: 10.3389/fimmu.2023.1111523.
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan J, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P
J Immunother Cancer. 2023; 11(1).
PMID: 36634919
PMC: 9843215.
DOI: 10.1136/jitc-2022-006133.
The Role of Mononuclear Phagocytes in the Testes and Epididymis.
Shi X, Zhao H, Kang Y, Dong X, Yu C, Xie Q
Int J Mol Sci. 2023; 24(1).
PMID: 36613494
PMC: 9820352.
DOI: 10.3390/ijms24010053.
Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
Sohl J, Hartmann A, Hahlbrock J, Bartneck J, Stassen M, Klein M
NPJ Vaccines. 2022; 7(1):112.
PMID: 36153349
PMC: 9509335.
DOI: 10.1038/s41541-022-00530-9.
The DNA damage repair-related gene is a potential biomarker in various malignancies.
Shao C, Wang Y, Pan M, Guo K, Molnar T, Kocher F
Transl Lung Cancer Res. 2022; 10(12):4600-4616.
PMID: 35070764
PMC: 8743528.
DOI: 10.21037/tlcr-21-973.
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 T cells in lymphoid tissue.
Rahman S, Yagnik B, Bally A, Morrow K, Wang S, Vanderford T
Sci Immunol. 2021; 6(63):eabh3034.
PMID: 34516743
PMC: 8500359.
DOI: 10.1126/sciimmunol.abh3034.
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma.
Patel S, Petroni G, Roszik J, Olson W, Wages N, Chianese-Bullock K
J Immunother Cancer. 2021; 9(8).
PMID: 34413169
PMC: 8378357.
DOI: 10.1136/jitc-2021-003220.
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity .
van den Bijgaart R, Schuurmans F, Futterer J, Verheij M, Cornelissen L, Adema G
Front Immunol. 2021; 12:617365.
PMID: 33936033
PMC: 8079760.
DOI: 10.3389/fimmu.2021.617365.
Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node.
Walsh S, Sheridan R, Lucas E, Doan T, Ware B, Schafer J
Elife. 2021; 10.
PMID: 33843587
PMC: 8116055.
DOI: 10.7554/eLife.62781.
Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer.
Fite B, Wang J, Kare A, Ilovitsh A, Chavez M, Ilovitsh T
Sci Rep. 2021; 11(1):927.
PMID: 33441763
PMC: 7806949.
DOI: 10.1038/s41598-020-80135-1.
Helpless Priming Sends CD8 T Cells on the Road to Exhaustion.
Busselaar J, Tian S, van Eenennaam H, Borst J
Front Immunol. 2020; 11:592569.
PMID: 33123174
PMC: 7573232.
DOI: 10.3389/fimmu.2020.592569.
Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.
Eberlein J, Davenport B, Nguyen T, Victorino F, Jhun K, van der Heide V
J Immunol. 2020; 205(8):2169-2187.
PMID: 32948687
PMC: 7541659.
DOI: 10.4049/jimmunol.2000253.
A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
Oba T, Hoki T, Yamauchi T, Keler T, Marsh H, Cao X
J Immunol. 2020; 205(7):1867-1877.
PMID: 32848036
PMC: 7511447.
DOI: 10.4049/jimmunol.2000347.
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.
Fujiki F, Tsuboi A, Morimoto S, Hashimoto N, Inatome M, Nakajima H
Cancer Immunol Immunother. 2020; 70(1):253-263.
PMID: 32696072
PMC: 10991126.
DOI: 10.1007/s00262-020-02675-9.
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy.
Amon L, Hatscher L, Heger L, Dudziak D, Lehmann C
Pharmaceutics. 2020; 12(7).
PMID: 32674488
PMC: 7408110.
DOI: 10.3390/pharmaceutics12070663.